The Payor's Dilemma: Navigating Personalized Medicine's Evolutions w/ Suzanne Belinson

The Promise of Personalized Medicine

While the healthcare industry innovates at an often unprecedented rate, payors grapple with the complexities of implementation and sustainability. From the payors vantage point, there is both excitement and trepidation surrounding personalized medicine’s rapid evolution.

Today’s guest, Suzanne Belinson emphasizes the critical role of diagnostics companies in helping healthcare systems manage this transformation effectively. Suzanne is the Vice President of Commercial Markets at Tempus, Inc. Tempus is a technology company focused on bringing the power of data and artificial intelligence to healthcare. Her role focuses on commercial growth for Tempus through the development and execution of partnerships with managed care organizations.

The conversation also dives into:

• Demonstrating the value of diagnostic testing
• How innovation can impact member retention
• The urgency to create sustainable platforms & payment models

—----

Stay connected with our host, Perry Dimas, here on LinkedIn!